Clinical trial
ASP 8825 Phase II Study-A Double- Blind, Placebo- Controlled Study in Patients With Painful Diabetic Polyneuropathy
NCT00508430 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ASP 8825 Phase II Study-A Double- Blind, Placebo- Controlled Study in Patients With Painful Diabetic Polyneuropathy
- Lead sponsor
- Astellas Pharma Inc
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2007
- Completion date
- November 30, 2008
- Enrollment
- 199 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.